<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2675">All eligible participants admitted Critical care unit which required constant rate of continuous RI infusion per standard MICU insulin infusion protocol for 24 consecutive hours were switched to receive single dose of glargine insulin subcutaneously by 100 % of their total daily insulin requirement calculated by cumulative dose of RI requirement in the previous 24 hours. The continuous insulin infusion was discontinued 2 hours after the transition. BG were monitored every 2 hours for the following 24 hours or until the study termination or discontinuation</p>
